Timothy Anderson v. HHS - Tdap, Guillain-Barré syndrome (2018)
Case summary [AI summaries can sometimes make mistakes]
Timothy Anderson filed a petition on June 27, 2016, alleging that the tetanus-diphtheria-acellular pertussis (Tdap) vaccine he received on July 22, 2013, caused him to suffer Guillain-Barré syndrome (GBS). He further alleged that he suffered residual effects for more than six months.
The Tdap vaccine is listed on the Vaccine Injury Table. Respondent denied that the vaccine caused or aggravated his injury.
However, the parties reached a stipulation for compensation. The Special Master adopted the stipulation, awarding Mr.
Anderson a lump sum of $235,000.00, payable by check to the petitioner, as compensation for all damages. The decision was filed on January 29, 2018.
The public decision does not describe the specific onset of symptoms, diagnostic tests, treatments, or expert witnesses. Petitioner counsel was Danielle A.
Strait of Maglio, Christopher & Toale. Respondent counsel was Adriana R.
Teitel of the United States Department of Justice. Special Master Christian J.
Moran issued the decision.
Theory of causation
Petitioner Timothy Anderson alleged that the Tdap vaccine administered on July 22, 2013, caused Guillain-Barré syndrome (GBS), a condition listed on the Vaccine Injury Table, and that residual effects lasted more than six months. Respondent denied causation. The parties entered into a stipulation for compensation, which was adopted by Special Master Christian J. Moran. The stipulation resulted in an award of $235,000.00 for all damages. The public text does not detail the specific mechanism of injury, expert testimony, or diagnostic findings. Petitioner counsel was Danielle A. Strait, and respondent counsel was Adriana R. Teitel. The decision was filed on January 29, 2018.
Source PDFs
USCOURTS-cofc-1_16-vv-00752